Long-term narrowband UVB phototherapy in vitiligo: Good results are correlated with a long period of continuous and constant therapy;Fototerapia UVB narrowband nella vitiligine: I buoni risultati sono correlati con un lungo periodo di terapia continua e costante

Giornale Italiano di Dermatologia e Venereologia

Volumn 139, Issue 3, 2004, Pages 171-179

  Brazzelli, V ^a   Prestinari, F ^a   Barbagallo, T ^a   Bellani, E ^a   Borroni, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Ultraviolet rays; Vitiligo; Vitiligo, therapy

Indexed keywords

ADULT; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; HUMAN; LONG TERM CARE; MALE; SAFETY; SKIN PIGMENTATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; VITILIGO;

EID: 3042704271     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001;44:999-1003.
2. Das PK, van den Wijngaard MJGJ, Wankowicz-Kalinska A, Le Poole C. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol 2001;22:130-6.
3. Palermo B, Campanelli R, Garbelli S, Mantovani S, Lantelme E, Brazzelli V et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001;117:326-32.
4. Mantovani S, Garbelli S, Palermo B, Campanelli R, Brazzelli V, Borroni G et al. Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+T cells in one vitiligo patient. J Invest Dermatol 2003;121:308-14.
5. Nordlund JJ, Halder RM, Grimes PE. Management of vitiligo. Dermatol Clin 1993;11:27-33.
6. Grimes PE. Vitiligo: an overview of therapeutic approaches. Dermatol Clin 1993;11:325-38.
7. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK et al. Guidelines of care for vitiligo. J Am Acad Dermatol 1996;35:620-6.
8. Njoo MD, Spus PI, Bos JD, Westerhof W, Bossuyt PMM. Non surgical repigmentation therapies in vitiligo. Arch Dermatol 1998;134: 1532-40.
9. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000;42:245-53.
10. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UVB radiation vs topical psoralen plus UVA. Arch Dermatol 1997; 133:1525-8.
11. Tjioe M, Gerritsen MJP, Juhlin L, Van de Kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002;82:369-72.
12. Benedetto AV. The psoralens. An historical perspective. Cutis 1977; 20:469-71.
13. Grimes PE. Psoralen photochemotherapy for vitiligo. Clin Dermatol 1997;15:921-6.
14. Kwok YKC, Anstey AV, Hawk JLM. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study. Clin Exp Dermatol 2002;27:104-10.
15. Cui J, Shen L, Wang G. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991;97:410-6.
16. Castanett J, Ortonne JP. Pathophysiology of vitiligo. Clin Dermatol 1997;15:845-51.
17. Fitzpatrick TB. Mechanisms of phototherapy of vitiligo. Arch Dermatol 1997;133:1591-2.
18. Horikawa T, Norris DA, Johnson TW, Zekman T, Dunscomb N, Bennion SD et al. DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. J Invest Dermatol 1996;106: 28-35.
19. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of this gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995;105:32-7.